mHealth is now indexed in PubMed/PMC: a tremendous step forward
News

mHealth is now indexed in PubMed/PMC: a tremendous step forward

Editorial Office

AME Publishing Company, Hong Kong, China

Correspondence to: Editorial Office. AME Publishing Company, Hong Kong, China. Email: editor@themhealth.org.

Received: 05 March 2017; Accepted: 10 March 2017; Published: 23 March 2017.

doi: 10.21037/mhealth.2017.03.02


On the eve of our second anniversary, we are excited to announce that mHealth has been officially accepted for inclusion in PubMed Central (PMC) (Figure 1). Inclusion in this extensive biomedical digital database and search engine ensures that publications from mHealth will be exposed to more readers and experts. All previously published content on mHealth will be retrievable on PubMed within 1–2 months. mHealth would like to extend our sincere appreciation for the enthusiastic and vigorous support and contributions from our editorial board members, guest editors, reviewers, authors and readers.

Figure 1 mHealth.

As an open access and peer-reviewed e-journal, mHealth has made significant progress since its launch in March 2015. During the past two years, we have had 39 members around the world join the editorial board (Figure 2) and published 74 original articles (Figure 3). Impressively, our website page views have been increasing significantly in these past 2 years, reaching 3,248 views in February 2017 (Figure 4).

Figure 2 Distribution of editorial board members.
Figure 3 The number of articles published on mHealth since its launch.
Figure 4 Page views of mHealth website since its launch.

Together with our board members, guest editors and authors, the editorial team of mHealth aims to develop the journal into a rigorous platform and capture the imagination of doctors, patients, innovators, and entrepreneurs. Being indexed in PubMed/PMC is an important step forward in achieving this goal. We look forward to working with our friends to take the journal to the next level in 2017 and beyond.


mHealth’s Publisher: AME Publishing Company

AME Publishing Company (www.amegroups.com) is an international publisher of medical books and journals that owns more than 30 English-language international journals covering different fields of medicine, including oncology, pulmonology, cardiothoracic disease and urology. Each journal features peer-reviewed original contributions, comprehensive reviews and editorials, as well as current case reports. AME Publishing Company has an integrated system featuring a professional and highly competent editorial team to ensure that every part of our work, from sending author invitations to online publications, functions with high efficiency. Needless to say there is a robust electronic dissemination system for all our journals and articles. Currently, AME has 16 sister journals indexed by PubMed (PMC or MEDLINE), 15 of which are indexed in the Web of Science (SCIE or ESCI). Specifically, the two journals indexed by SCIE are Journal of Thoracic Disease and Translational Cancer Research. The 13 journals indexed by ESCI (Emerging Sources Citation Index)/WOS are: Annals of Cardiothoracic Surgery, Journal of Gastrointestinal Oncology, Cardiovascular Diagnosis and Therapy, Translational Andrology and Urology, Translational Gastroenterology and Hepatology, HepatoBiliary Surgery and Nutrition, Chinese Clinical Oncology, Annals of Translational Medicine, Translational Pediatrics, Gland Surgery, Annals of Palliative Medicine, Quantitative Imaging in Medicine and Surgery, and Translational Lung Cancer Research.


Acknowledgements

None.


Footnote

Conflicts of Interest: The author has no conflicts of interest to declare.

doi: 10.21037/mhealth.2017.03.02
Cite this article as: Editorial Office. mHealth is now indexed in PubMed/PMC: a tremendous step forward. mHealth 2017;3:9.

Refbacks

  • There are currently no refbacks.